Atrial Fibrillation Trial, Recruiting NCT07130773 Sponsor: Cardiocentro Ticino Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07130773
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with atrial fibrillation (an irregular heart rhythm), confirmed by a heart tracing test, a portable heart monitor, or an implanted heart device
  • People whose doctor has determined that a procedure to correct the irregular heart rhythm (called ablation) is an appropriate treatment option for them, based on current medical guidelines
  • People who are 18 years of age or older at the time of signing the consent form
  • People who have read, understood, and signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People who have previously had an ablation procedure or surgery on the left side of their heart
  • People who have a blood clot inside their heart
  • People who have had persistent atrial fibrillation (continuously irregular heart rhythm) for more than 3 years
  • People who have serious problems with one of their heart valves (specifically, severe leaking or moderate-to-severe narrowing of the mitral valve)
  • People who are pregnant — all women under the age of 50 will have a blood test to check for pregnancy before being considered for inclusion

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 (0) 91 811 51 11

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cardiocentro Ticino
Registry
ClinicalTrials.gov
Start date
10 November 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Fluoroscopy time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov